Pemetrexed Baxter สหภาพยุโรป - ฟินแลนด์ - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastiset aineet - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Lidocaine Baxter 10 mg/ml injektioneste, liuos ฟินแลนด์ - ฟินแลนด์ - Fimea (Suomen lääkevirasto)

lidocaine baxter 10 mg/ml injektioneste, liuos

baxter holding b.v. - lidocaine hydrochloride - injektioneste, liuos - 10 mg/ml - lidokaiini

Lidocaine Baxter 20 mg/ml injektioneste, liuos ฟินแลนด์ - ฟินแลนด์ - Fimea (Suomen lääkevirasto)

lidocaine baxter 20 mg/ml injektioneste, liuos

baxter holding b.v. - lidocaine hydrochloride - injektioneste, liuos - 20 mg/ml - lidokaiini

Metoclopramide Baxter 5 mg/ml injektioneste, liuos ฟินแลนด์ - ฟินแลนด์ - Fimea (Suomen lääkevirasto)

metoclopramide baxter 5 mg/ml injektioneste, liuos

baxter holding b.v. - metoclopramide hydrochloride - injektioneste, liuos - 5 mg/ml - metoklopramidi